Who is affected by this change?

This affects Blue Cross Blue Shield of Rhode Island Oncology, Hematology, Plastic Surgery, General Surgery providers in RI on All Plans plans.

When does this change take effect?

This change is effective Jul 1, 2019.

Back to dashboard

All PlansCoverageLow impact

New policies

Blue Cross Blue Shield of Rhode Island·RI · Oncology, Hematology, Plastic Surgery +1 more·Physician / Facility

Effective date

Jul 1, 2019

We identified it

Jun 20, 2026

Days to comply

—

Summary

Blue Cross Blue Shield of Rhode Island has created two new medical policies effective July 1, 2019: coverage for Elzonris (tagraxofusp-erzs) and surgical treatments for breast cancer-related lymphedema. Full policy details with specific coverage criteria and billing requirements are available on the provider website.

Action Required

Action needed

Review full policy text on bcbsri.com under Medical Policy heading to understand coverage criteria and billing requirements for Elzonris (tagraxofusp-erzs) and breast cancer lymphedema surgeries. Update billing procedures accordingly if your practice treats these conditions.

Related policy hubs

Blue Cross Blue Shield of Rhode Island policies RI policy changes Oncology Hematology Plastic Surgery General Surgery